Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.91 |
| ▸ | ADIPOR2 | Q86V24 | 1/20 | 0.80 |
| ▸ | ADIPOR1 | Q96A54 | 1/20 | 0.80 |
| ▸ | USP2 | O75604 | 1/20 | 0.75 |
| ▸ | CCR8 | P51685 | 2/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.65 |
| ▸ | MCHR1 | Q99705 | 3/20 | 0.63 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | FAAH | O00519 | 1/20 | 0.60 |
| ▸ | BCHE | P06276 | 1/20 | 0.60 |
| ▸ | ACHE | P22303 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6509291 | 0.92 | CCR8 (0.82) | POLBADIPOR2ADIPOR1USP2CCR8 | |
| SCHEMBL24514563 | 0.91 | POLB (0.86) | POLBADIPOR2ADIPOR1USP2L3MBTL1 | |
| SCHEMBL17945987 | 0.90 | POLB (0.84) | POLBADIPOR2ADIPOR1USP2L3MBTL1 | |
| SCHEMBL17938602 | 0.89 | ADIPOR2 (1.00) | POLBADIPOR2ADIPOR1USP2L3MBTL1 | |
| SCHEMBL17946000 | 0.88 | POLB (0.74) | POLBADIPOR2ADIPOR1USP2CCR8 | |
| SCHEMBL24514564 | 0.88 | ADIPOR2 (0.82) | POLBADIPOR2ADIPOR1USP2L3MBTL1 | |
| SCHEMBL5129236 | 0.86 | MCHR1 (0.83) | POLBADIPOR2ADIPOR1USP2SIGMAR1 | |
| SCHEMBL17950883 | 0.86 | ADIPOR2 (0.90) | POLBADIPOR2ADIPOR1USP2L3MBTL1 | |
| SCHEMBL24514573 | 0.84 | POLB (0.74) | POLBADIPOR2ADIPOR1USP2L3MBTL1 | |
| SCHEMBL25568935 | 0.84 | POLB (0.74) | POLBADIPOR2ADIPOR1USP2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170298051-A1 | ACTIVATOR OF ADIPONECTIN RECEPTOR | THE UNIVERSITY OF TOKYO (JP) | 2017-10-19 | — | — | US | disclosed |
| US-20170298051-A1 | ACTIVATOR OF ADIPONECTIN RECEPTOR | THE UNIVERSITY OF TOKYO (JP) | 2017-10-19 | — | — | US | disclosed |
| EP-3053911-A1 | ADIPONECTIN RECEPTOR-ACTIVATING COMPOUND | The University of Tokyo (JP) | 2016-08-10 | — | — | EP | disclosed |
| US-20160214967-A1 | ACTIVATOR OF ADIPONECTIN RECEPTOR | THE UNIVERSITY OF TOKYO (JP) | 2016-07-28 | — | — | US | disclosed |
| US-20160214967-A1 | ACTIVATOR OF ADIPONECTIN RECEPTOR | THE UNIVERSITY OF TOKYO (JP) | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160214967-A1 | ACTIVATOR OF ADIPONECTIN RECEPTOR | ADIPOR1, ADIPOR2, CCKAR | POLB 4574/4885ADIPOR2 2/4885ADIPOR1 1/4885 |
| US-20170298051-A1 | ACTIVATOR OF ADIPONECTIN RECEPTOR | ADIPOR1, ADIPOR2, CCKAR | POLB 4574/4885ADIPOR2 2/4885ADIPOR1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.